Our partnership references

 

All of Orion's strategic partnerships share a common basis. They are managed for the long term and related to our central business areas.

Strategic partnerships can be global, regional or local, depending on the subject matter, and their focus may be ion commercial collaboration or even even individual projects or processes.

The regular partnership agreement covers a single or few countries within one geographical region. Typically the partnerships involve operational functions such as manufacturing and logistics.

As the name indicates, strategic partnerships are central to Orion's strategy. They can be global or multi-regional, operating in the USA, Japan, and/or major European countries, and/or they may involve technologies considered central for Orion's businesses, depending on the case.

The common nominator for the majority of our collaborations is that they are cross-functional, complex co-operations vased on reciprocity. In strategic partnerships, joint efforts in R&D, marketing, promotion and/or manufacturing are common.

 

Our Strategic Partners

 

Product

Partner Orion's role

 

Comtan®

 

Novartis

 

New Drug Application

 

Stalevo®

 

Novartis

 

New Drug Application

 

Precedex®

 

Hospira

 

Co-development

 

Dexdomitor®
Domitor®
Antisedan®
Domosedan®

 

Pfizer Animal Health

 

New Drug Application

 

Hormonal therapies 

 

Schering-Plough

Upsher-Smith

 

New Drug Application

Co-development

 

Easyhaler®

 

Hexal

Berlin-Chemie/Menarini

Abdi Ibrahim

Oncology-related research Aurigene Discovery Technologies Limited Co-development


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Updated Oct 6th 2009